What is NDC 0121-4027?

0121-4027 is the product NDC for Lithium, Lithium citrate 8 meq/5mL solution, listed with the FDA by PAI Holdings, LLC dba PAI Pharma. It has 1 package NDC, shown above in 10- and 11-digit form.

PAI Holdings, LLC dba PAI Pharma, NDC labeler code 0121. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lithium?

7 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lithium NDC 0121-4027 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0121-4027Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00121-4027Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0121-4027-94	00121402794	3 TRAY in 1 CASE (0121-4027-94) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-4027-05)Marketed from Apr 14, 2026

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lithium
Generic name (nonproprietary): lithium
Active ingredients: Lithium citrate — 8 meq/5mL
Dosage form: Solution
Route: Oral
Labeler: PAI Holdings, LLC dba PAI PharmaNDC labeler code 0121
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 070755
Marketing start: Apr 14, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 0121-4027_0a44f05f-6cf7-4264-a228-1372bf0e9154SPL ID 0a44f05f-6cf7-4264-a228-1372bf0e9154SPL set ID 677b20c4-84f0-4716-aca3-aead3bbe1283RxCUI 756059UNII 5Z6E9K79YV
Pharmacologic class: Mood Stabilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400121402794 followed by a unit qualifier and the quantity

Package 00121-4027-94. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 31, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Lithium is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar I disorder: Treatment of acute manic and mixed episodes in patients 7 years and older [see Clinical Studies ( 14 )] Maintenance treatment in patients 7 years and older [see Clinical Studies ( 14 )] Lithium is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar I disorder: Treatment of acute manic and mixed episodes in patients 7 years and older ( 1 ) Maintenance treatment in patients 7 years and older ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0121-4027

What is NDC 0121-4027?: 0121-4027 is the product NDC for Lithium, Lithium citrate 8 meq/5mL solution, listed with the FDA by PAI Holdings, LLC dba PAI Pharma. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lithium.
What is the active ingredient?: Lithium citrate.
Who is the labeler?: PAI Holdings, LLC dba PAI Pharma, NDC labeler code 0121. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lithium?: 7 other product NDCs are listed under this name. See all Lithium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lithium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lithium	Lithium citrate 8 meq/5mL	SolutionOral	PAI Holdings, LLC dba PAI Pharma	0121-1027	00121-1027-16
Lithiumlithium citrate	Lithium citrate 8 meq/5mL	SolutionOral	Precision Dose, Inc.	68094-077	68094-0077-62
Lithium	Lithium citrate 8 meq/5mL	SolutionOral	REMEDYREPACK INC.	70518-4227	70518-4227-0070518-4227-02
Lithium	Lithium citrate 8 meq/5mL	SolutionOral	Saptalis Pharmaceuticals, LLC	71656-072	71656-0072-1671656-0072-50
Lithium	Lithium citrate 8 meq/5mL	SolutionOral	Advagen Pharma Ltd	72888-172	72888-0172-46
Lithium	Lithium citrate 8 meq/5mL	SolutionOral	Atlantic Biologicals Corp.	17856-1172	17856-1172-01
Lithiumlithium bromatum	Lithium bromide 3 [hp_X]/mL	LiquidOral	Marco Pharma International LLC.	60986-1019	60986-1019-0360986-1019-04

Other NDCs under ANDA 070755

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 070755
Product	Strength	Form · route	Labeler	Product NDC
Lithium	Lithium citrate 8 meq/5mL	SolutionOral	PAI Holdings, LLC dba PAI Pharma	0121-1027